Bad Reaction

Brownlee, Shannon
October 2002
New Republic;10/28/2002, Vol. 227 Issue 18, p15
Criticizes the plans of the administration of U.S. President George W. Bush for ensuring public safety in the event of a smallpox outbreak. Failure of bioterrorism advisers to estimate the number of citizens who suffer serious reactions to the vaccine; Problem with the availability of drugs that have shown promise in treating vaccine side effects; Inability of the Bush administration to get experimental anti-bioterrorism drugs into production.


Related Articles

  • Ring vaccination versus mass vaccination in event of a smallpox attack. Chuen-Yen Lau; Wahl, Bryan; Foo, Wendell K. S. // Hawaii Medical Journal;Feb2005, Vol. 64 Issue 2, p34 

    Since vaccination is critical in responding to smallpox exposure, vaccination strategies must be evaluated during bioterrorism preparedness. Information on historical factors, smallpox characteristics, public health capabilities and hypothetical attack scenarios was used to evaluate major...

  • A Different View of Smallpox and Vaccination. Mack, Thomas // New England Journal of Medicine;1/30/2003, Vol. 348 Issue 5, p460 

    Contends that smallpox vaccination would provide little protection from bioterrorist attacks and that the cost in deaths from vaccine complications would outweigh any benefits. Suggests efforts be made to facilitate rapid diagnosis; Education of the public seen as necessary; Selected medical...

  • Smallpox Vaccination: Implementation of National Program Faces Challenges: GAO-03-578.  // GAO Reports;4/30/2003, p1 

    Amid growing concerns about a potential smallpox attack, the Centers for Disease Control and Prevention (CDC) is working with 62 state, local, and territorial jurisdictions to implement the civilian part of the National Smallpox Vaccination Program. The goal is to increase the nation's response...

  • Estimation of the Duration of Vaccine-induced Residual Protection Against Severe and Fatal Smallpox Based on Secondary Vaccination Failure. Nishiura, H.; Eichner, M. // Infection;Oct2006, Vol. 34 Issue 5, p241 

    Understanding the loss of vaccine-induced immunity against smallpox is essential in determining the fraction of those who are still protected in the present population and in constructing effective countermeasures against bioterrorist attacks. Three small Australian outbreaks from the 1880s to...

  • Countering the Smallpox Threat. Rauch, Jonathan // Atlantic;Dec2001, Vol. 288 Issue 5, p50 

    The article discusses the possible use of smallpox by terrorists. The difficulties raised by the limitations of the smallpox vaccine are addressed, including the immunity length, in some cases lasting as little as three years, and kills or permanently injures 1 in every 300,000 people injected...

  • Dutch health service is asked to draw up smallpox contingency plans.  // BMJ: British Medical Journal (International Edition);2/22/2003, Vol. 326 Issue 7386, p414 

    Reports that the Dutch Ministry of Health has requested local health agencies to complete contingency plans for the mass vaccination of the Dutch population against smallpox. Statement of the ministry that although there is no threat of an outbreak of the disease, that political instability in...

  • Analysis of Historical Data Suggests Long-lasting Protective Effects of Smallpox Vaccination. Martin Eichner // American Journal of Epidemiology;10/15/2003, Vol. 158 Issue 8, p717 

    More than half of the US population has received the smallpox vaccine, but it is unknown what fraction is still protected against infection and disease. Residual protection and age-dependent case-fatality ratios have therefore been widely neglected in the current bioterrorism debate. The author...

  • US hospitals balking at smallpox vaccination. Sibbald, Barbara // CMAJ: Canadian Medical Association Journal;4/15/2003, Vol. 168 Issue 8, p1034 

    Focuses on concerns about the safety of smallpox vaccination in the United States. Data regarding the expectation for serious reaction to immunization, according to studies by the U.S. Centers for Disease Control, with between 14 and 52 of one million people experiencing potentially...

  • Smallpox Vaccine: Who Should Get It?  // Child Health Alert;Oct2002, Vol. 20, p1 

    Focuses on the efforts of the U.S. government to lead in the production of smallpox vaccine resulting from the increase threat of bioterrorism.


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics